Cynthia N. Oliver
MedImmune
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Cynthia N. Oliver.
Journal of Pharmaceutical Sciences | 2009
Joshua D. Ramsey; Michelle L. Gill; Tim J. Kamerzell; E. Shane Price; Sangeeta B. Joshi; Steven M. Bishop; Cynthia N. Oliver; C. Russell Middaugh
Understanding the relationship between protein dynamics and stability is of paramount importance to the fields of biology and pharmaceutics. Clarifying this relationship is complicated by the large amount of experimental data that must be generated and analyzed if motions that exist over the wide range of timescales are to be included. To address this issue, we propose an approach that utilizes a multidimensional vector-based empirical phase diagram (EPD) to analyze a set of dynamic results acquired across a temperature-pH perturbation plane. This approach is applied to a humanized immunoglobulin G1 (IgG1), a protein of major biological and pharmaceutical importance whose dynamic nature is linked to its multiple biological roles. Static and dynamic measurements are used to characterize the IgG and to construct both static and dynamic EPDs. Between pH 5 and 8, a single, pH-dependent transition is observed that corresponds to thermal unfolding of the IgG. Under more acidic conditions, evidence exists for the formation of a more compact, aggregation resistant state of the immunoglobulin, known as A-form. The dynamics-based EPD presents a considerably more detailed pattern of apparent phase transitions over the temperature-pH plane. The utility and potential applications of this approach are discussed.
Journal of Chromatography A | 1998
Yun Yuan; Erica Shane; Cynthia N. Oliver
A quantitative reversed-phase high-performance liquid chromatography (RP-HPLC) method has been developed to detect the L1 subunit protein from virus-like particles (VLPs) of human papillomavirus (HPV). The method utilizes heat treatment with a buffer consisting of 50 mM Tris, pH 8.0 containing 8 M guanidine-HCl and 10% 2-mercaptoethanol to dissociate the VLPs into monomeric L1. Following dissociation, the sample is injected onto a C4 or C8 column. The L1 protein is eluted as a single, clearly resolved peak. Elution conditions have been optimized to enhance the separation of L1 from other contaminants. Based on spike recovery studies and sodium dodecyl sulfate-polyacrylamide gel electrophoretic analysis this method is suitable for quantitation of various partially purified in-process samples and can be used to facilitate purification process development.
Journal of Pharmaceutical Sciences | 2007
Nicholas R. Harn; C. Allan; Cynthia N. Oliver; Charles Russell Middaugh
Archive | 2003
Cynthia N. Oliver; Christian B. Allan; Stephen Chang
Archive | 2003
Cynthia N. Oliver; Erica Shane; Benjamin S. Isaacs; Christian B. Allan; Stephen Chang
Quality by Design for Biopharmaceuticals: Principles and Case Studies | 2008
Mark Schenerman; Milton J. Axley; Cynthia N. Oliver; Kripa Ram; Gail F. Wasserman
BioProcessing Journal | 2015
Timothy Hahn; Brian Webb; John Kutney; Ed Fix; Nancy Nidel; James Wong; Dana Jendrek; Celia Baula; Jody Lichaa; Mike Sowers; Ye Liu; John P. Higgins; Kwan-Ho Roh; Zheng Meng; Cynthia N. Oliver; Erica Shane; Larry R. Ellingsworth; Sarathi Boddapati; Christi Mcdowell-Patterson; Ziping Wei; Oleg Borisov; Win Cheung; Jingning Li; Victor Gavrilov; Kathleen Callahan; Karin Lövgren Bengtsson; Magnus Sävenhed; Mats Sjölund; Susanna Macmillar; Malin Schenerfelt
Encyclopedia of Cell Technology | 2003
Govind Rao; Marco A. Cacciuttolo; Cynthia N. Oliver
Archive | 2017
Christopher Forespring; Cynthia N. Oliver; Erica Shane; Min Wan; Randall Lapcevich
Archive | 2013
Min Wan; Christopher Forespring; Randall Lapcevich; Erica Shane; Cynthia N. Oliver